Lima Lídia M, Castro Paulo, Machado Alexandre L, Fraga Carlos Alberto M, Lugnier Claire, de Moraes Vera Lúcia Gonçalves, Barreiro Eliezer J
Laboratório de Avaliação e Síntese de Substâncias Bioativas, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Brazil.
Bioorg Med Chem. 2002 Sep;10(9):3067-73. doi: 10.1016/s0968-0896(02)00152-9.
This paper describes the synthesis and anti-inflammatory activity of new N-phenyl-phthalimide sulfonamides (3a-e) and the isosters N-phenyl-phthalimide amides (4a-e), designed as hybrids of thalidomide (1) and aryl sulfonamide phosphodiesterase inhibitor (2). In these series, compound 3e (LASSBio 468), having a sulfonyl-thiomorpholine moiety, showed potent inhibitory activity on LPS-induced neutrophil recruitment with ED(50)=2.5mg kg(-1), which was correlated with its inhibitory effect on TNF-alpha level.
本文描述了新型N-苯基-邻苯二甲酰亚胺磺酰胺(3a-e)及其电子等排体N-苯基-邻苯二甲酰亚胺酰胺(4a-e)的合成与抗炎活性,它们被设计为沙利度胺(1)与芳基磺酰胺磷酸二酯酶抑制剂(2)的杂合物。在这些系列化合物中,具有磺酰基-硫代吗啉部分的化合物3e(LASSBio 468)对脂多糖诱导的中性粒细胞募集表现出强效抑制活性,半数有效剂量(ED50)为2.5mg kg-1,这与其对肿瘤坏死因子-α水平的抑制作用相关。